Paying users zone. Data is covered by 
.
Get to Eli Lilly & Co. for $19.99, or
get to entire website for at least 3 months from $49.99.
Profitability Analysis
Quarterly Data
Difficulty: Beginner
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Ratios (Summary)
Eli Lilly & Co., profitability ratios (quarterly data)
Based on: 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28).
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Eli Lilly & Co.’s gross profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Eli Lilly & Co.’s operating profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Eli Lilly & Co.’s net profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Eli Lilly & Co.’s ROE improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Eli Lilly & Co.’s ROA improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Gross Profit Margin
Eli Lilly & Co., gross profit margin calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28).
Q4 2018 Calculations
1 Gross profit margin = 100
× (Gross marginQ4 2018
+ Gross marginQ3 2018
+ Gross marginQ2 2018
+ Gross marginQ1 2018)
÷ (RevenueQ4 2018
+ RevenueQ3 2018
+ RevenueQ2 2018
+ RevenueQ1 2018)
= 100
× ( + + + )
÷ ( + + + )
=
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Eli Lilly & Co.’s gross profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Operating Profit Margin
Eli Lilly & Co., operating profit margin calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28).
Q4 2018 Calculations
1 Operating profit margin = 100
× (Operating income (loss)Q4 2018
+ Operating income (loss)Q3 2018
+ Operating income (loss)Q2 2018
+ Operating income (loss)Q1 2018)
÷ (RevenueQ4 2018
+ RevenueQ3 2018
+ RevenueQ2 2018
+ RevenueQ1 2018)
= 100 × ( + + + )
÷ ( + + + )
=
| Ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Eli Lilly & Co.’s operating profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Net Profit Margin
Eli Lilly & Co., net profit margin calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28).
Q4 2018 Calculations
1 Net profit margin = 100
× (Net income (loss)Q4 2018
+ Net income (loss)Q3 2018
+ Net income (loss)Q2 2018
+ Net income (loss)Q1 2018)
÷ (RevenueQ4 2018
+ RevenueQ3 2018
+ RevenueQ2 2018
+ RevenueQ1 2018)
= 100 × ( + + + )
÷ ( + + + )
=
| Ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Eli Lilly & Co.’s net profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Return on Equity (ROE)
Eli Lilly & Co., ROE calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28).
Q4 2018 Calculations
1 ROE = 100
× (Net income (loss)Q4 2018
+ Net income (loss)Q3 2018
+ Net income (loss)Q2 2018
+ Net income (loss)Q1 2018)
÷ Total Eli Lilly and Company shareholders’ equity
= 100 × ( + + + )
÷ =
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Eli Lilly & Co.’s ROE improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Return on Assets (ROA)
Eli Lilly & Co., ROA calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28).
Q4 2018 Calculations
1 ROA = 100
× (Net income (loss)Q4 2018
+ Net income (loss)Q3 2018
+ Net income (loss)Q2 2018
+ Net income (loss)Q1 2018)
÷ Total assets
= 100 × ( + + + )
÷ =
| Ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Eli Lilly & Co.’s ROA improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |